{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:24:55Z","timestamp":1782779095526,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijrobp.2010.10.040","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T15:51:51Z","timestamp":1302105111000},"page":"1809-1815","source":"Crossref","is-referenced-by-count":75,"title":["Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK\/T-Cell Lymphoma"],"prefix":"10.1016","volume":"82","author":[{"given":"Ye-Xiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.10.040_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2257.2000.00307.x","article-title":"Angiocentric nasal T\/natural killer cell lymphoma: A single center study of prognostic factors in 108 patients","volume":"22","author":"Aviles","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2006-07-033142","article-title":"Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK\/T-cell lymphoma: Results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"109","author":"Bossard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib4","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal NK\/T-cell lymphoma: A study of 136 cases from the International Peripheral T-cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hyi006","article-title":"Treatment outcome of angiocentric T-cell and NK\/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy","volume":"35","author":"Kim","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdn147","article-title":"Clinical heterogeneity of extranodal NK\/T-cell lymphoma, nasal type: A national survey of the Korean Cancer Study Group","volume":"19","author":"Kim","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib8","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","article-title":"Extranodal nasal type NK\/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy","volume":"41","author":"Lee","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib11","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","article-title":"Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: A single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib16","first-page":"285","article-title":"Role of radiotherapy in the combined treatment of patients with early-stage extranodal nasal-type NK\/T-cell lymphoma and analysis of prognostic factors","volume":"18","author":"Yang","year":"2009","journal-title":"Chin J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12032-009-9288-7","article-title":"Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer\/T-celllymphoma","volume":"27","author":"Ma","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","article-title":"Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment","volume":"18","author":"Kim","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","article-title":"Primary non-Hodgkin\u2019s lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy","volume":"83","author":"Li","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib22","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal T\/NK-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib24","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib26","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","article-title":"Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin\u2019s lymphoma: Eastern Cooperative Oncology Group study 1484","volume":"22","author":"Horning","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","article-title":"Treatment of non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: Radiotherapy versus chemotherapy versus combined therapy","volume":"32B","author":"Aviles","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib29","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib30","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: Consortium for improving survival of lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1259\/0007-1285-55-657-645","article-title":"Radiotherapy of polymorphic reticulosis","volume":"55","author":"Halperin","year":"1982","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0360-3016(88)90300-8","article-title":"Polymorphic reticulosis limited to the upper aerodigestive tract: Natural history and radiotherapeutic considerations","volume":"15","author":"Smalley","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/02841869309083888","article-title":"Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis)","volume":"32","author":"Sobrevilla-Calvo","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(95)01668-6","article-title":"Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period","volume":"38","author":"Chen","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib35","first-page":"1507","article-title":"A clinical study of 57 patients with extranodal natural killer\/T-cell lymphoma, nasal-type","volume":"31","author":"Aikemu","year":"2008","journal-title":"J\u00a0Xinjiang Med Univ"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: Radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.radonc.2009.08.045","article-title":"A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type in the upper aerodigestive tract","volume":"93","author":"Ma","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"A clinical study of 115 patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1259\/bjr\/83758373","article-title":"A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer\/T-cell lymphoma","volume":"82","author":"Tomita","year":"2009","journal-title":"Brit J Radiol"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/10428190600562823","article-title":"First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy radiotherapy is active in stage I\/II extranodal NK\/T-cell lymphoma","volume":"47","author":"Lee","year":"2006","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib41","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than international prognostic index in stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal-type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2010.10.040_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal-type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161003467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161003467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T14:50:50Z","timestamp":1543848650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161003467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S036030161003467X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.040","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}